Shares of Zogenix (NASDAQ:ZGNX), a small-cap pharmaceutical company with a focus on disorders of the central never system, fell hard during the month of September.
Was the sell-off justified? Read the short presentation below to get all of the details.
Brian Feroldi has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.